TGFbeta induces cell death and changes in liver cells
Author Information
Author(s): Sharon Sheahan, Christopher O. Bellamy, Stephen N. Harland, David J. Harrison, Sandrine Prost
Primary Institution: Queen's Medical Research Institute, University of Edinburgh
Hypothesis
How do p53, p21Cip1, and Rb deficiencies affect TGFβ-induced apoptosis and EMT in hepatocytes?
Conclusion
TGFβ induces apoptosis in hepatocytes regardless of p53, p21Cip1, and Rb status, but these proteins slightly modulate the process.
Supporting Evidence
- TGFβ induces high levels of apoptosis in hepatocytes regardless of their genetic background.
- Deficiencies in p53 and p21Cip1 decrease sensitivity to TGFβ-induced apoptosis.
- TGFβ treatment leads to morphological changes in hepatocytes that are independent of p53, p21Cip1, and Rb status.
Takeaway
When liver cells are treated with a substance called TGFβ, they can die, and this happens no matter what genes they have. Some genes can change how sensitive the cells are to this treatment.
Methodology
Primary mouse hepatocytes were treated with TGFβ for 24 to 96 hours, and apoptosis was quantified using morphology and cleaved-caspase 3 immunostaining.
Limitations
The study primarily focuses on specific gene deficiencies and may not account for other factors influencing TGFβ responses.
Participant Demographics
Male mice, aged 6–12 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website